1086PN-terminal B-type natriuretic peptide (NT-proBNP) as an independed prognostic marker for patients with newly diagnosed multiple myeloma complicated by dialysis-dependent renal failure
ConclusionsAccording to our data, NT-proBNP> 7400 pg/ml are associated with the severity of kidney damage and the risk of non-cardiac mortality in ND MM patients.Legal entity responsible for the studyThe authors.FundingHas not received any funding.DisclosureAll authors have declared no conflicts of interest.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research
More News: Amyloidosis | Cancer & Oncology | Cardiology | Cardiovascular | Chemotherapy | Dialysis | Heart | Hemodialysis | Legislation | Myeloma | Pathology | Renal Failure | Study | Urology & Nephrology